AAV1-CMV-SERCA2a gene therapy

· Assistance Publique - Hôpitaux de Paris

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AAV1-CMV-SERCA2a gene therapy, covering 2017-08-29 to 2017-08-29. Get the full timeline:

Most recent: Clinical Trial Update: AAV1-CMV-Serca2a GENe Therapy Trial in Heart Failure [Phase 2]